These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9282781)

  • 21. Protective immunity against equine herpesvirus type-1 (EHV-1) infection in mice induced by recombinant EHV-1 gD.
    Zhang Y; Smith PM; Tarbet EB; Osterrieder N; Jennings SR; O'Callaghan DJ
    Virus Res; 1998 Jul; 56(1):11-24. PubMed ID: 9784062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity.
    Guo PX; Goebel S; Perkus ME; Taylor J; Norton E; Allen G; Languet B; Desmettre P; Paoletti E
    J Virol; 1990 May; 64(5):2399-406. PubMed ID: 2157895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of glycoprotein B of equine herpesvirus 1 expressed by a recombinant baculovirus.
    Munro KI; Wellington JE; Love DN; Whalley JM
    Vet Microbiol; 1999 Aug; 68(1-2):49-57. PubMed ID: 10501161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models.
    Tsujimura K; Yamanaka T; Kondo T; Fukushi H; Matsumura T
    J Vet Med Sci; 2006 Oct; 68(10):1029-38. PubMed ID: 17085880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA-mediated immunization with glycoprotein D of equine herpesvirus 1 (EHV-1) in a murine model of EHV-1 respiratory infection.
    Ruitenberg KM; Walker C; Wellington JE; Love DN; Whalley JM
    Vaccine; 1999 Jan; 17(3):237-44. PubMed ID: 9987159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Equine herpesvirus 1 (EHV-1) glycoprotein D DNA inoculation in horses with pre-existing EHV-1/EHV-4 antibody.
    Ruitenberg KM; Love DN; Gilkerson JR; Wellington JE; Whalley JM
    Vet Microbiol; 2000 Sep; 76(2):117-27. PubMed ID: 10946142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterisation of IE and UL5 gene products of equine herpesvirus 1 using DNA inoculation of mice.
    Koen MT; Walker C; Wellington JE; Love DN; Whalley JM
    Arch Virol; 2000; 145(12):2677-86. PubMed ID: 11205113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the glycoprotein D gene products of equine herpesvirus 1 using a prokaryotic cell expression vector.
    Love DN; Bell CW; Whalley JM
    Vet Microbiol; 1992 Mar; 30(4):387-94. PubMed ID: 1316667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effects of intranasal immunization with recombinant glycoprotein d in pregnant BALB/c mice challenged with different strains of equine herpesvirus 1.
    Fuentealba NA; Zanuzzi CN; Scrochi MR; Sguazza GH; Bravi ME; Cid de la Paz V; Corva SG; Portiansky EL; Gimeno EJ; Barbeito CG; Galosi CM
    J Comp Pathol; 2014 Nov; 151(4):384-93. PubMed ID: 25124330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inoculation with DNA encoding the glycoprotein gp2 reduces severity of equine herpesvirus 1 infection in a mouse respiratory model.
    Learmonth GS; Love DN; Gilkerson JR; Wellington JE; Whalley JM
    Arch Virol; 2003 Sep; 148(9):1805-13. PubMed ID: 14505091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of equine herpesvirus-1 (EHV-1) glycoprotein B in a murine model of EHV-1-induced abortion.
    Kukreja A; Walker C; Fitzmaurice T; Awan A; Love DN; Whalley JM; Field HJ
    Vet Microbiol; 1998 Aug; 62(4):303-11. PubMed ID: 9791876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization with glycoprotein C of equine herpesvirus-1 is associated with accelerated virus clearance in a murine model.
    Tewari D; Nair SV; De Ungria MC; Lawrence GL; Hayden M; Love DN; Field HJ; Whalley JM
    Arch Virol; 1995; 140(4):789-97. PubMed ID: 7794119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A hamster model of equine herpesvirus type 1 (EHV-1) infection; passive protection by monoclonal antibodies to EHV-1 glycoproteins 13, 14 and 17/18.
    Stokes A; Allen GP; Pullen LA; Murray PK
    J Gen Virol; 1989 May; 70 ( Pt 5)():1173-83. PubMed ID: 2471805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine profiles and long-term virus-specific antibodies following immunization of CBA mice with equine herpesvirus 1 and viral glycoprotein D.
    Zhang Y; Smith PM; Frampton AR; Osterrieder N; Jennings SR; O'Callaghan DJ
    Viral Immunol; 2003; 16(3):307-20. PubMed ID: 14583146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization of BALB/c mice with DNA encoding equine herpesvirus 1 (EHV-1) glycoprotein D affords partial protection in a model of EHV-1-induced abortion.
    Walker C; Ruitenberg KM; Love DN; Millar Whalley J
    Vet Microbiol; 2000 Oct; 76(3):211-20. PubMed ID: 10973696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Equine herpesvirus-1 strain KyA, a candidate vaccine strain, reduces viral titers in mice challenged with a pathogenic strain, RacL.
    Colle CF; Tarbet EB; Grafton WD; Jennings SR; O'Callaghan DJ
    Virus Res; 1996 Aug; 43(2):111-24. PubMed ID: 8864201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells.
    Sisk WP; Bradley JD; Leipold RJ; Stoltzfus AM; Ponce de Leon M; Hilf M; Peng C; Cohen GH; Eisenberg RJ
    J Virol; 1994 Feb; 68(2):766-75. PubMed ID: 8289380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for involvement of equine herpesvirus 1 glycoprotein B in cell-cell fusion.
    Wellington JE; Love DN; Whalley JM
    Arch Virol; 1996; 141(1):167-75. PubMed ID: 8629945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.